PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Pulmatrix, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$1.42+0.06 (+4.41%)

Close on Oct 19, 2026

Market cap: $5.19M
P/E (TTM): –
Dividend yield: –

Pulmatrix, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Cash & Equivalents	4.09	9.52	19	36	54	32	23	2.56	3.75	4.18	19	0.45	1.43
Cash & Short-Term Investments	4.09	9.52	19	36	54	32	23	2.56	3.75	4.18	19	0.45	1.43
Receivables	–	–	0.93	1.30	0.07	0.08	7.20	–	–	–	–	–	–
Prepaid Expenses & Other	0.04	0.40	0.74	1.07	0.87	0.72	0.78	0.72	0.70	0.58	1.56	0.38	–
Other Current Assets	–	–	–	–	–	–	–	–	–	–	0.21	0.05	–
Total Current Assets	4.13	9.92	21	38	55	32	31	3.28	4.25	4.76	20	0.83	–
Property, Plant & Equipment	–	–	1.16	0.24	0.32	0.36	0.27	0.39	0.61	0.79	0.69	0.47	–
Gross Property, Plant & Equipment	–	–	2.89	2.98	2.96	2.84	2.56	2.51	3.48	3.46	3.29	3.00	–
Accumulated Depreciation	–	–	-1.74	-2.75	-2.64	-2.48	-2.29	-2.12	-2.87	-2.67	-2.61	-2.53	–
Operating Lease Right-of-Use Assets	–	–	10	0.71	2.09	1.49	0.63	1.21	–	–	–	–	–
Goodwill	–	–	–	–	–	3.58	3.58	11	11	11	16	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	7.53	–	–
Other Long-Term Assets	–	0.01	0.18	0.39	–	–	–	–	–	–	–	–	–
Total Assets	4.14	9.94	34	41	59	38	36	15	16	17	45	1.55	–
Accounts Payable	0.27	0.81	1.92	1.19	0.84	0.85	0.60	1.18	0.46	0.75	1.09	0.22	–
Accrued Expenses	–	–	–	–	1.23	2.03	2.51	1.70	2.16	1.32	1.49	3.54	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	0	3.22	2.59	1.03	–	–
Current Debt	–	–	–	–	–	–	–	0	3.22	2.59	1.03	–	–
Current Portion of Leases	–	–	0.43	0.86	1.43	1.14	0.68	1.28	–	–	–	–	–
Deferred Revenue (Current)	–	–	0.62	1.34	0.94	4.17	13	0	–	–	–	–	–
Total Current Liabilities	0.33	0.93	3.91	5.02	4.44	8.18	17	2.88	5.84	4.65	3.61	43	–
Long-Term Debt	–	–	–	–	–	–	–	–	–	3.22	5.69	–	–
Long-Term Leases	–	–	8.33	–	0.86	0.61	–	–	–	–	–	–	–
Operating Lease Liabilities	–	–	8.76	0.86	2.29	1.74	0.68	1.28	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	–	–	–	2.96	–	–
Total Liabilities	0.33	1.00	16	9.84	11	15	25	2.88	5.84	7.90	12	45	–
Total Debt	–	–	–	–	–	–	–	0	3.22	5.80	6.72	–	–
Preferred Stock	–	–	–	–	1.08	–	–	–	–	–	–	0	–
Common Stock	–	–	–	–	–	0.00	0.00	0	0	0.00	0.00	0.00	–
Additional Paid-In Capital	306	306	306	305	301	258	226	206	184	165	161	23	–
Retained Earnings	-302	-297	-288	-273	-255	-234	-215	-195	-174	-156	-128	-102	–
Shareholders' Equity	3.81	8.95	18	31	47	23	11	12	10	8.76	33	-79	-75
Total Equity	3.81	8.95	18	31	47	23	11	12	10	8.76	33	-79	-75
Total Liabilities & Equity	4.14	9.94	34	41	59	38	36	15	16	17	45	1.55	–
Shares Outstanding(shares)	3.65	3.65	3.65	3.64	3.22	1.81	1.00	0.25	0.11	0.07	0.07	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -80.9%

Financial strength

Current ratio: 4.70
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 314.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 2.03
Dividend yield: –